169 related articles for article (PubMed ID: 18755820)
1. Increase of CD4+TNF{alpha}+IL-2-T cells in cerebrospinal fluid of multiple sclerosis patients.
Shi N; Kawano Y; Matsuoka T; Mei F; Ishizu T; Ohyagi Y; Kira J
Mult Scler; 2009 Jan; 15(1):120-3. PubMed ID: 18755820
[TBL] [Abstract][Full Text] [Related]
2. Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls.
Haegele KF; Stueckle CA; Malin JP; Sindern E
J Neuroimmunol; 2007 Feb; 183(1-2):168-74. PubMed ID: 17084910
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.
Ishizu T; Osoegawa M; Mei FJ; Kikuchi H; Tanaka M; Takakura Y; Minohara M; Murai H; Mihara F; Taniwaki T; Kira J
Brain; 2005 May; 128(Pt 5):988-1002. PubMed ID: 15743872
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis.
Buttinelli C; Toma L; Falcone MM; Salvetti M; Ristori G; Barnaba V; Fieschi C
Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):79-83. PubMed ID: 1345744
[TBL] [Abstract][Full Text] [Related]
5. Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patientswith relapsing-remitting multiple sclerosis.
Gausling R; Trollmo C; Hafler DA
Clin Immunol; 2001 Jan; 98(1):11-7. PubMed ID: 11141321
[TBL] [Abstract][Full Text] [Related]
6. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
[TBL] [Abstract][Full Text] [Related]
7. A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFalpha, and Granzyme B in CSF.
Takahashi Y; Mine J; Kubota Y; Yamazaki E; Fujiwara T
Epilepsia; 2009 Jun; 50(6):1419-31. PubMed ID: 19175398
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
9. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.
Jilek S; Schluep M; Rossetti AO; Guignard L; Le Goff G; Pantaleo G; Du Pasquier RA
Clin Immunol; 2007 Apr; 123(1):105-13. PubMed ID: 17188575
[TBL] [Abstract][Full Text] [Related]
10. Immunomonitoring measures in relapsing-remitting multiple sclerosis.
Matsui M; Araya SI; Wang HY; Matsushima K; Saida T
J Neuroimmunol; 2004 Mar; 148(1-2):192-9. PubMed ID: 14975601
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.
Maxeiner HG; Rojewski MT; Schmitt A; Tumani H; Bechter K; Schmitt M
Brain Behav Immun; 2009 Jan; 23(1):134-42. PubMed ID: 18771722
[TBL] [Abstract][Full Text] [Related]
12. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
Habib HM; Taher TE; Isenberg DA; Mageed RA
Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
[TBL] [Abstract][Full Text] [Related]
13. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid.
Mellergård J; Edström M; Vrethem M; Ernerudh J; Dahle C
Mult Scler; 2010 Feb; 16(2):208-17. PubMed ID: 20007431
[TBL] [Abstract][Full Text] [Related]
14. Features of intrathecal immunoglobulins in patients with multiple sclerosis.
Di Pauli F; Gredler V; Kuenz B; Lutterotti A; Ehling R; Gneiss C; Schocke M; Deisenhammer F; Reindl M; Berger T
J Neurol Sci; 2010 Jan; 288(1-2):147-50. PubMed ID: 19828154
[TBL] [Abstract][Full Text] [Related]
15. The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Blauth K; Zhang X; Chopra M; Rogan S; Markovic-Plese S
Clin Immunol; 2015 Apr; 157(2):121-32. PubMed ID: 25596452
[TBL] [Abstract][Full Text] [Related]
16. Glatiramer acetate-specific human CD8(+) T cells: increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment.
Dressel A; Vogelgesang A; Brinkmeier H; Mäder M; Weber F
J Neuroimmunol; 2006 Dec; 181(1-2):133-40. PubMed ID: 17084909
[TBL] [Abstract][Full Text] [Related]
17. Cellular immunoregulatory mechanisms in the central nervous system: characterization of noninflammatory and inflammatory cerebrospinal fluid lymphocytes.
Matsui M; Mori KJ; Saida T
Ann Neurol; 1990 Jun; 27(6):647-51. PubMed ID: 2360801
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility to apoptosis of CD4+T cells expressing CCR5 and CXCR3 in patients with MS.
Julià E; Edo MC; Horga A; Montalban X; Comabella M
Clin Immunol; 2009 Dec; 133(3):364-74. PubMed ID: 19740704
[TBL] [Abstract][Full Text] [Related]
19. Increased IL-13-producing T cells in ALS: positive correlations with disease severity and progression rate.
Shi N; Kawano Y; Tateishi T; Kikuchi H; Osoegawa M; Ohyagi Y; Kira J
J Neuroimmunol; 2007 Jan; 182(1-2):232-5. PubMed ID: 17097743
[TBL] [Abstract][Full Text] [Related]
20. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis.
Stüve O; Cepok S; Elias B; Saleh A; Hartung HP; Hemmer B; Kieseier BC
Arch Neurol; 2005 Oct; 62(10):1620-3. PubMed ID: 16216948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
